CMO

Dr. Ben Greenberg received his Bachelor of Arts degree from Johns Hopkins University and his Master’s Degree in Molecular Microbiology and Immunology from the Johns Hopkins School of Public Health in Baltimore, Maryland. He attended medical school at Baylor College of Medicine in Houston, Texas, then completed an internship in medicine at Rush Presbyterian-St. Luke’s Medical Center in Chicago, Illinois. Ben left Rush for a residency in neurology at The Johns Hopkins Hospital in Baltimore, MD, eventually joining the faculty within the division of neuroimmunology at Hopkins becoming the Co-Director of the Transverse Myelitis Center and the Director of the Encephalitis Center. In January of 2009 he was recruited to the faculty at the University of Texas Southwestern Medical Center where he was named Deputy Director of the Multiple Sclerosis Program and Director of the new Transverse Myelitis and Neuromyelitis Optica Program. That same year he established the Pediatric Demyelinating Disease Program at Children’s Medical Center Dallas. He serves as Vice Chair of Clinical and Translational Research for the Department of Neurology.

Dr. Greenberg is focused on rare autoimmune disorders of the central nervous system (e.g. transverse myelitis, neuromyelitis optica, ADEM and autoimmune encephalitis). He splits his clinical time between seeing both adult and pediatric patients. He routinely consults on the inpatient units of University Hospital, Zale Lipshy, Parkland and Children’s. His translational research focus has been in both the diagnosis and treatment of transverse myelitis, neuromyelitis optica, encephalitis and multiples sclerosis. He is actively involved in developing better ways to diagnose and prognosticate for patients with these disorders. He has led an effort to improve biorepository development and has created uniform protocols for sample handling and analysis. As part of this initiative his research has identified novel biomarkers that may be able to distinguish between patients with various neurologic disorders. He also coordinates trials that study new treatments to prevent neurologic damage and restore function to those who have already been affected. These have included multiple phase 1 studies.

Dr. Greenberg has been a member of the American Academy of Neurology since 2004 and a regular educator at AAN sponsored national and regional meetings. He is a fellow of the American Academy of Neurology and the American Neurological Association.